These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17204702)

  • 1. In vivo evaluation of P-glycoprotein modulation of 8 PET radioligands used clinically.
    Ishiwata K; Kawamura K; Yanai K; Hendrikse NH
    J Nucl Med; 2007 Jan; 48(1):81-7. PubMed ID: 17204702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro-to-in vivo prediction of P-glycoprotein-based drug interactions at the human and rodent blood-brain barrier.
    Hsiao P; Bui T; Ho RJ; Unadkat JD
    Drug Metab Dispos; 2008 Mar; 36(3):481-4. PubMed ID: 18057117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport.
    Syvänen S; Lindhe O; Palner M; Kornum BR; Rahman O; Långström B; Knudsen GM; Hammarlund-Udenaes M
    Drug Metab Dispos; 2009 Mar; 37(3):635-43. PubMed ID: 19047468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can celecoxib affect P-glycoprotein-mediated drug efflux? A microPET study.
    de Vries EF; Doorduin J; Vellinga NA; van Waarde A; Dierckx RA; Klein HC
    Nucl Med Biol; 2008 May; 35(4):459-66. PubMed ID: 18482683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of [11C]XR9576 to assess the function of drug efflux transporters using PET.
    Kawamura K; Konno F; Yui J; Yamasaki T; Hatori A; Yanamoto K; Wakizaka H; Takei M; Nengaki N; Fukumura T; Zhang MR
    Ann Nucl Med; 2010 Jun; 24(5):403-12. PubMed ID: 20361276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verapamil P-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human data.
    Hsiao P; Sasongko L; Link JM; Mankoff DA; Muzi M; Collier AC; Unadkat JD
    J Pharmacol Exp Ther; 2006 May; 317(2):704-10. PubMed ID: 16415090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-animal PET study of adenosine A(1) receptors in rat brain: blocking receptors and raising extracellular adenosine.
    Paul S; Khanapur S; Rybczynska AA; Kwizera C; Sijbesma JW; Ishiwata K; Willemsen AT; Elsinga PH; Dierckx RA; van Waarde A
    J Nucl Med; 2011 Aug; 52(8):1293-300. PubMed ID: 21764782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of P-glycoprotein on intestinal absorption and brain penetration of antiallergic agent bepotastine besilate.
    Ohashi R; Kamikozawa Y; Sugiura M; Fukuda H; Yabuuchi H; Tamai I
    Drug Metab Dispos; 2006 May; 34(5):793-9. PubMed ID: 16455807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New positron emission tomography tracer [(11)C]carvedilol reveals P-glycoprotein modulation kinetics.
    Bart J; Dijkers EC; Wegman TD; de Vries EG; van der Graaf WT; Groen HJ; Vaalburg W; Willemsen AT; Hendrikse NH
    Br J Pharmacol; 2005 Aug; 145(8):1045-51. PubMed ID: 15951832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a P-glycoprotein inhibitor, Cyclosporin A, on the disposition in rodent brain and blood of the 5-HT1A receptor radioligand, [11C](R)-(-)-RWAY.
    Liow JS; Lu S; McCarron JA; Hong J; Musachio JL; Pike VW; Innis RB; Zoghbi SS
    Synapse; 2007 Feb; 61(2):96-105. PubMed ID: 17117422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First visualization of adenosine A(2A) receptors in the human brain by positron emission tomography with [11C]TMSX.
    Ishiwata K; Mishina M; Kimura Y; Oda K; Sasaki T; Ishii K
    Synapse; 2005 Feb; 55(2):133-6. PubMed ID: 15543628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein activity and biological response.
    Vaalburg W; Hendrikse NH; Elsinga PH; Bart J; van Waarde A
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):257-60. PubMed ID: 16043202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No inhibitory effect on P-glycoprotein function at blood-brain barrier by clinical dose of clarithromycin: a human PET study with [¹¹C]verapamil.
    Arakawa R; Ito H; Okumura M; Morimoto T; Seki C; Takahashi H; Takano A; Suhara T
    Ann Nucl Med; 2010 Feb; 24(2):83-7. PubMed ID: 20069466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain.
    Elsinga PH; Hendrikse NH; Bart J; van Waarde A; Vaalburg W
    Mol Imaging Biol; 2005; 7(1):37-44. PubMed ID: 15912274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of P-glycoprotein inhibition on the distribution of the tricyclic antidepressant nortriptyline over the blood-brain barrier.
    Ejsing TB; Linnet K
    Hum Psychopharmacol; 2005 Mar; 20(2):149-53. PubMed ID: 15624117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
    Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing the uptake of dextromethorphan in the CNS of rats by concomitant administration of the P-gp inhibitor verapamil.
    Marier JF; Deschênes JL; Hage A; Seliniotakis E; Gritsas A; Flarakos T; Beaudry F; Vachon P
    Life Sci; 2005 Oct; 77(23):2911-26. PubMed ID: 15964599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of P-glycoprotein function by procyanidine on blood-brain barrier.
    He L; Zhao C; Yan M; Zhang LY; Xia YZ
    Phytother Res; 2009 Jul; 23(7):933-7. PubMed ID: 19172664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration and degree of cyclosporin induced P-glycoprotein inhibition in the rat blood-brain barrier can be studied with PET.
    Syvänen S; Blomquist G; Sprycha M; Höglund AU; Roman M; Eriksson O; Hammarlund-Udenaes M; Långström B; Bergström M
    Neuroimage; 2006 Sep; 32(3):1134-41. PubMed ID: 16857389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional differences in capillary density, perfusion rate, and P-glycoprotein activity: a quantitative analysis of regional drug exposure in the brain.
    Zhao R; Pollack GM
    Biochem Pharmacol; 2009 Oct; 78(8):1052-9. PubMed ID: 19523457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.